Volume 62, Issue 3, Pages (September 2012)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Maria Carmen Mir, Cesar Ercole, Andrew Stephenson

Volume 60, Issue 5, Pages (November 2011)

Volume 71, Issue 2, Pages (February 2017)

European Urology Focus

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 5, Pages (May 2013)

Volume 58, Issue 1, Pages (July 2010)

Volume 65, Issue 4, Pages (April 2014)

European Urology Oncology

Volume 73, Issue 1, Pages (January 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 3, Pages (September 2015)

Volume 51, Issue 3, Pages (March 2007)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 53, Issue 5, Pages (May 2008)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 64, Issue 3, Pages (September 2013)

Volume 72, Issue 5, Pages (November 2017)

Prostate Cancer Epidemic in Sight?

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology Philipp.

Volume 63, Issue 1, Pages (January 2013)

Toxicities of Targeted Therapy and Their Management in Kidney Cancer

Bladder Cancer: A Major Public Health Issue

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

Volume 61, Issue 5, Pages (May 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 69, Issue 5, Pages (May 2016)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 68, Issue 1, Pages (July 2015)

Volume 61, Issue 6, Pages (June 2012)

Volume 63, Issue 5, Pages (May 2013)

Contemporary Management of Postchemotherapy Testis Cancer

Volume 69, Issue 4, Pages (April 2016)

Volume 64, Issue 3, Pages (September 2013)

European Urology Oncology

Prostate Cancer Epidemic in Sight?

Volume 71, Issue 6, Pages (June 2017)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Volume 67, Issue 6, Pages (June 2015)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Volume 69, Issue 6, Pages (June 2016)

Volume 50, Issue 5, Pages (November 2006)

Role of Checkpoint Inhibition in Localized Bladder Cancer

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Testicular Cancer Variations in Time and Space in Europe

Volume 74, Issue 4, Pages (October 2018)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology Oncology

European Urology is “Your” Journal

European Urology Oncology

Volume 75, Issue 2, Pages (February 2019)

Economic Burden of Bladder Cancer Across the European Union

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Volume 52, Issue 4, Pages (October 2007)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Joaquim Bellmunt European Urology Supplements

Volume 52, Issue 1, Pages (July 2007)

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 62, Issue 3, Pages 523-533 (September 2012) A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. Galsky, Noah M. Hahn, Seth P. Lerner, Malcolm Mason, Thomas Powles, Cora N. Sternberg, Guru Sonpavde European Urology Volume 62, Issue 3, Pages 523-533 (September 2012) DOI: 10.1016/j.eururo.2012.05.048 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Proposed strategy to incorporate perioperative systemic therapy for cisplatin-eligible urothelial carcinoma of the bladder (UCB). TURBT=transurethral resection of bladder tumor. European Urology 2012 62, 523-533DOI: (10.1016/j.eururo.2012.05.048) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 Proposed strategy to incorporate perioperative systemic therapy for cisplatin-ineligible or refusing patients with urothelial carcinoma of the bladder (UCB). LVI=lymphovascular invasion; RC=radical cystectomy; TURBT=transurethral resection of bladder tumor. European Urology 2012 62, 523-533DOI: (10.1016/j.eururo.2012.05.048) Copyright © 2012 European Association of Urology Terms and Conditions